Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Genialis the RNA biomarker company today announced a collaboration with Cleveland Clinic one of the worlds leading academic medical centers to develop AIpowered tools that help doctors identify the most effective treatment options for patients with p...
Santhera Pharmaceuticals today notes that Health Canada has approved AGAMREE vamorolone for the treatment of Duchenne muscular dystrophy DMD in patients aged years and older following Priority Review marking the first approved treatment for the dise...
Roche announced today that the US Food and Drug Administration FDA has approved Tecentriq atezolizumab and Tecentriq Hybreza atezolizumab and hyaluronidasetqjs in combination with lurbinectedin Zepzelca for the maintenance treatment of adult patients...
UCB Pharma and Tanner Pharma Group today announced they have initiated a partnership in Southeast Asia to enable access to innovative treatments for patients with epilepsy We are proud to work with UCB to provide a means for epilepsy patients in Sout...
VERAXA Biotech an emerging leader in designing novel cancer therapies and proposed deSPAC acquisition target of Voyager Acquisition Corp NASDAQVACHVoyager and Secarna Pharmaceuticals GmbH
Parexel a leading global clinical research organization CRO providing insightsdriven Clinical and Consulting solutions to the worlds life sciences industry today announced a partnership with Weave Bio a pioneer in AInative regulatory
Debiopharm wwwdebiopharmcom a privatelyowned Swissbased biopharmaceutical company today announced having signed a license agreement for SunRock Biopharmas SRB an HERHER antibody SunRock Biopharma
Hinge Bio Inc a privatelyheld biotechnology company engaged in the discovery and development of innovative medicines announced it has entered into a collaboration and license agreement with Kyorin Pharmaceutical Co Ltd Kyorin
Made Scientific a leading cell therapy contract development and manufacturing organization CDMO and Syenex a synthetic biology company specializing in bestinclass targeted delivery technologies
Cell Therapies Pty Ltdand Teijin Limited announced today that they have signed a Memorandum of Understanding MoU to strengthen regional infrastructure for cell and gene therapies CGT leveraging
